Maze Therapeutics, Inc. (MAZE)
30.37
-1.34
(-4.23%)
USD |
NASDAQ |
Mar 27, 16:00
30.37
0.00 (0.00%)
After-Hours: 16:12
Maze Therapeutics EPS Diluted (Quarterly) : -0.7007 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -1.155 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.5436 |
| MapLight Therapeutics, Inc. | -1.807 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.57M |
| Total Expenses (Quarterly) | 34.57M |
| Enterprise Value | 1.246B |
| Earnings Yield | -9.36% |
| Normalized Earnings Yield | -9.376 |